Alternatives to Gabapentin for Diabetic Nerve Pain
If gabapentin, pregabalin, or other oral medications haven't given you adequate relief from painful diabetic neuropathy — or if the side effects are unacceptable — the NS100 by NeuroDynamics Global may be an option. It's an FDA-cleared 20-day non-pharmacologic neuromodulation therapy that targets nerve pain without a daily pill and without opioids.
Why patients look beyond gabapentin and pregabalin
Gabapentin (Neurontin) and pregabalin (Lyrica) are common first-line oral medications for painful diabetic neuropathy. They help many patients, but a meaningful share either don't get adequate relief, can't tolerate the side effects — drowsiness, dizziness, weight gain, swelling, brain fog — or want a non-pharmacologic option.
Other oral options like duloxetine, tricyclic antidepressants, and opioids also carry side effects and risks. For patients who have already tried first-line medications without adequate relief, a non-drug therapy may be the right next step.
Key facts
- Non-pharmacologic — no daily pill, no systemic drug exposure
- Non-opioid therapy
- FDA-cleared Class II medical device for chronic PDN pain
- 20-day temporary therapy — no permanent implant
- Placed in a minimally invasive in-office procedure
- Covered by Medicare for eligible patients
Why it matters
No daily medication
NS100 is a device-based therapy — no pill schedule, no systemic side effects from oral drugs.
20-day protocol
A defined, time-limited course of therapy — worn for 20 days, then removed.
FDA-cleared
Class II peripheral nerve stimulation system cleared for chronic pain associated with PDN.
Targeted nerve therapy
Delivers gentle electrical stimulation directly to the nerves causing your pain.
How NS100 by NeuroDynamics Global works without medication
NS100 is a peripheral nerve stimulation (PNS) system. Instead of working through the bloodstream like an oral drug, NS100 delivers programmable electrical pulses directly to peripheral nerves to help modulate pain signals at the source.
A thin lead is placed in a minimally invasive in-office procedure under topical anesthesia. You wear the device for 20 days, then the leads are removed by your provider in a simple in-office visit — nothing is left in the body.
Because NS100 is non-pharmacologic, you avoid the systemic side effects of oral neuropathic pain medications. Eligibility and expected outcomes are determined by your treating provider; individual results vary.
How NS100 compares with common medication options
Compared with gabapentin and pregabalin, NS100 avoids the sedation, dizziness, swelling, and weight gain that often lead patients to stop taking them. Compared with duloxetine and tricyclics, it avoids systemic antidepressant exposure. Compared with opioids, it carries no risk of opioid dependence.
NS100 is not the right fit for every patient. Your provider will review your medication history, candidacy, and goals before recommending therapy.
Frequently asked questions
Ready to learn if NS100 is right for you?
Connect with our team. We'll help you understand candidacy, coverage, and next steps.